Prediction of Response to IUCD Associated Menorrhagia Using Doppler

Ain Shams University156 enrolled

Overview

Studying the efficacy of uterine artery doppler in predicting response to mefenamic acid in women having IUCD associated menorrhagia

Study Type

INTERVENTIONAL

Allocation

Purpose

SCREENING

Masking

NONE

Enrollment

156

Conditions

Women's Health: Amenorrhea/Dysmenorrhea

Interventions

DopplerDEVICE

Doing doppler for women having IUCD associated menorrhagia

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 35 Years

Medical Language ↔ Plain English

Inclusion Criteria: * women in chile bearing period (age 20-35 yrs ) with history of regular menstrual cycle presenting with recent onset of more then three months menorrhagia after IUCD "copper T 380 A" insertion Exclusion Criteria: * history of bleeding tendency * history of abnormal uterine bleeding due to other causes * history of active liver disease * history of antiplatelet or anticoagulant intake in the last month * history of thyroid disease * history of endometritis * history of allergy to NSAIDs * Adenomyosis * women having contraindications to use NSAIDs e.g. peptic ulcer * Insulin dependant diabetes mellitus

Locations (1)

AinshamsU

Cairo, Abbaseya, Egypt

Outcomes

Primary Outcomes

Resistance index and Pulsitality index (Predicting the response to IUCD associated menorrhagia)

Base line uterine artery doppler is done to the patient complaining of IUCD related menorrhagia prior to treatment , parameters of doppler are: resistance index and pulsitality index, then the patient takes mefenamic acid tablets 500 mg three times daily for five days, assessment of response whether the patient is responder or not is done using pictorial blood loss assessment chart then base line doppler parameters in responders and non responders are compared to correlate the response to base line doppler parameters

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.